×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Gastric Cancer

Wayne Kuznar
Surgical palliation improved quality of live and solid food intake in patients with certain types of gastric cancer, according to a recent study.
Silas Inman
A recent study found that Opdivo improves survival in patients with gastric or gastroesophageal junction (GEJ) cancer. 
Laura Panjwani
The JAVELIN trial showed that many patients with gastric cancer could benefit from immunotherapy. 
Debu Tripathy, MD
Since chemotherapy can offer only a limited amount of help in fighting gastroesophageal cancers, a growing emphasis on prevention — as well as on the development of immunotherapies — will be extremely important.
Erin Moore
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Arlene Weintraub
In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.
Erik Ness
Diagnoses in younger people and two causative infections are providing clues about how to better prevent and treat gastric cancer.
Erik Ness
The decision to remove one's stomach may be difficult, but it can also be life-saving.
Jason M. Broderick
Results from new clinical trials signal a role for the immunotherapy Opdivo in the treatment of gastric cancer and heavily pretreated esophageal cancer.
Pamela Grossman
I will be out on the street in New York City on November 1 to cheer on James Blake.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other